2 events to decide market trends in 2025; 2 pharma stocks to buy: Dipan Mehta
Dipan Mehta, Director, Elixir Equities, says the earning season and the Trump presidency are the two important events or trends to look out for in 2025. Mehta is hoping for the best because the September quarter was pretty disappointing. Be it a mild turnaround in December quarter or a continuation of September quarter – that will determine the trend for the market. The market can go either which way. It can rally back up to its all-time highs or correct further from these levels.
Mehta also says that there is a good trading opportunity within the banks, especially tier II PSU banks. He is more positive on them than the private sector banks, but it is a short term, maybe a few months, one or two quarter type of a play. In the medium to long term, he is underweight banks.
What is your take on the fertiliser counters? How do you see this subsidy hike coming and which stock do you think will be the biggest beneficiary of this hike? Dipan Mehta: Coming to your question about subsidy increase, it is much needed because the soil composition also needs the adequate amount of DAP and other phosphatic fertilisers. Obviously, the biggest beneficiary of this is going to be Coromandel International, which is India's largest DAP and phosphatic fertiliser manufacturer and it is a step in the right direction. Generally, fertiliser companies have not created great value. They are great trading opportunities because of a lot of government interference and the effect that monsoon has on their sales.
But by and large, within the
